{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T21:03:14Z","timestamp":1763499794908},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,21]]},"DOI":"10.7759\/cureus.32764","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:26:49Z","timestamp":1671611209000},"source":"Crossref","is-referenced-by-count":5,"title":["Effect of Vitamin E on Clinical Outcomes in Patients With Non-alcoholic Fatty Liver Disease: A Meta-Analysis"],"prefix":"10.7759","author":[{"given":"Jithin","family":"Karedath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiba","family":"Javed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima","family":"Ahsan Talpur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bihari","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anmol","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Husam","family":"Kivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venkata","family":"Anirudh Chunchu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamsha","family":"Hirani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)","volume":"8 Suppl 1","author":"Bellentani S","year":"2009","unstructured":"Bellentani S, Marino M. Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Ann Hepatol. 2009, 8 Suppl 1:S4-S8.","journal-title":"Ann Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1210\/er.2012-1009","article-title":"Diabetes and nonalcoholic fatty liver disease: a pathogenic duo","volume":"34","author":"Williams KH","year":"2013","unstructured":"Williams KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM. Diabetes and nonalcoholic fatty liver disease: a pathogenic duo. Endocr Rev. 2013, 34:84-129. 10.1210\/er.2012-1009","journal-title":"Endocr Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi ZM","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016, 64:73-84. 10.1002\/hep.28431","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1126\/science.56.1458.650","article-title":"On the existence of a hitherto unrecognized dietary factor essential for reproduction","volume":"56","author":"Evans HM","year":"1922","unstructured":"Evans HM, Bishop KS. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science. 1922, 56:650-651. 10.1126\/science.56.1458.650","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000343106","article-title":"A history of vitamin E","volume":"61","author":"Niki E","year":"2012","unstructured":"Niki E, Traber MG. A history of vitamin E. Ann Nutr Metab. 2012, 61:207-212. 10.1159\/000343106","journal-title":"Ann Nutr Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2014.11.018","article-title":"Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials","volume":"31","author":"Sato K","year":"2015","unstructured":"Sato K, Gosho M, Yamamoto T, et al.. Vitamin E has a beneficial effect on nonalcoholic fatty liver disease: a meta-analysis of randomized controlled trials. Nutrition. 2015, 31:923-930. 10.1016\/j.nut.2014.11.018","journal-title":"Nutrition"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101710","article-title":"Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis","volume":"37","author":"Podszun MC","year":"2020","unstructured":"Podszun MC, Alawad AS, Lingala S, et al.. Vitamin E treatment in NAFLD patients demonstrates that oxidative stress drives steatosis through upregulation of de-novo lipogenesis. Redox Biol. 2020, 37:101710. 10.1016\/j.redox.2020.101710","journal-title":"Redox Biol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00204-008-0394-7","article-title":"Effect of alpha-tocopherol on carbon tetrachloride intoxication in the rat liver","volume":"83","author":"Iida C","year":"2009","unstructured":"Iida C, Fujii K, Koga E, et al.. Effect of alpha-tocopherol on carbon tetrachloride intoxication in the rat liver. Arch Toxicol. 2009, 83:477-483. 10.1007\/s00204-008-0394-7","journal-title":"Arch Toxicol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/00365520903114912","article-title":"Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice","volume":"44","author":"Nan YM","year":"2009","unstructured":"Nan YM, Wu WJ, Fu N, et al.. Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice. Scand J Gastroenterol. 2009, 44:1121-1131. 10.1080\/00365520903114912","journal-title":"Scand J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal AJ","year":"2010","unstructured":"Sanyal AJ, Chalasani N, Kowdley KV, et al.. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010, 362:1675-1685. 10.1056\/NEJMoa0907929","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2018-136364","article-title":"Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials","volume":"95","author":"Amanullah I","year":"2019","unstructured":"Amanullah I, Khan YH, Anwar I, Gulzar A, Mallhi TH, Raja AA. Effect of vitamin E in non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomised controlled trials. Postgrad Med J. 2019, 95:601-611. 10.1136\/postgradmedj-2018-136364","journal-title":"Postgrad Med J"},{"key":"ref12","article-title":"Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study","volume":"19","author":"Aller R","year":"2015","unstructured":"Aller R, Izaola O, G\u00f3mez S, et al.. Effect of silymarin plus vitamin E in patients with non-alcoholic fatty liver disease. A randomized clinical pilot study. Eur Rev Med Pharmacol Sci. 2015, 19:3118-3124.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001369","article-title":"Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial","volume":"31","author":"Anushiravani A","year":"2019","unstructured":"Anushiravani A, Haddadi N, Pourfarmanbar M, Mohammadkarimi V. Treatment options for nonalcoholic fatty liver disease: a double-blinded randomized placebo-controlled trial. Eur J Gastroenterol Hepatol. 2019, 31:613-617. 10.1097\/MEG.0000000000001369","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0167","article-title":"Role of vitamin E for nonalcoholic steatohepatitis in patients with type 2 diabetes: a randomized controlled trial","volume":"42","author":"Bril F","year":"2019","unstructured":"Bril F, Biernacki DM, Kalavalapalli S, et al.. Role of vitamin E for nonalcoholic steatohepatitis in patients with type 2 diabetes: a randomized controlled trial. Diabetes Care. 2019, 42:1481-1488. 10.2337\/dc19-0167","journal-title":"Diabetes Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine JE","year":"2011","unstructured":"Lavine JE, Schwimmer JB, Van Natta ML, et al.. Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. JAMA. 2011, 305:1659-1668. 10.1001\/jama.2011.520","journal-title":"JAMA"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2006.03161.x","article-title":"Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease","volume":"24","author":"Nobili V","year":"2006","unstructured":"Nobili V, Manco M, Devito R, Ciampalini P, Piemonte F, Marcellini M. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2006, 24:1553-1561. 10.1111\/j.1365-2036.2006.03161.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22336","article-title":"Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial","volume":"48","author":"Nobili V","year":"2008","unstructured":"Nobili V, Manco M, Devito R, et al.. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology. 2008, 48:119-128. 10.1002\/hep.22336","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5152\/tjg.2018.17297","article-title":"Effects of delta-tocotrienol supplementation on liver enzymes, inflammation, oxidative stress and hepatic steatosis in patients with nonalcoholic fatty liver disease","volume":"29","author":"Pervez MA","year":"2018","unstructured":"Pervez MA, Khan DA, Ijaz A, Khan S. Effects of delta-tocotrienol supplementation on liver enzymes, inflammation, oxidative stress and hepatic steatosis in patients with nonalcoholic fatty liver disease. Turk J Gastroenterol. 2018, 29:170-176. 10.5152\/tjg.2018.17297","journal-title":"Turk J Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/00005176-200401000-00012","article-title":"Vitamin E treatment in pediatric obesity-related liver disease: a randomized study","volume":"38","author":"Vajro P","year":"2004","unstructured":"Vajro P, Mandato C, Franzese A, et al.. Vitamin E treatment in pediatric obesity-related liver disease: a randomized study. J Pediatr Gastroenterol Nutr. 2004, 38:48-55. 10.1097\/00005176-200401000-00012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.1598","article-title":"Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children","volume":"14","author":"Wang CL","year":"2008","unstructured":"Wang CL, Liang L, Fu JF, et al.. Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children. World J Gastroenterol. 2008, 14:1598-1602. 10.3748\/wjg.14.1598","journal-title":"World J Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-10-200511150-00009","article-title":"The metabolic syndrome as a predictor of nonalcoholic fatty liver disease","volume":"143","author":"Hamaguchi M","year":"2005","unstructured":"Hamaguchi M, Kojima T, Takeda N, et al.. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Ann Intern Med. 2005, 143:722-728. 10.7326\/0003-4819-143-10-200511150-00009","journal-title":"Ann Intern Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90235-6","article-title":"Nonalcoholic steatohepatitis: an expanded clinical entity","volume":"107","author":"Bacon BR","year":"1994","unstructured":"Bacon BR, Farahvash MJ, Janney CG, et al.. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology. 1994, 107:1103-1109. 10.1016\/0016-5085(94)90235-6","journal-title":"Gastroenterology"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2015.21.4.379","article-title":"Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: a propensity score-matched cohort study","volume":"21","author":"Kim GH","year":"2015","unstructured":"Kim GH, Chung JW, Lee JH, et al.. Effect of vitamin E in nonalcoholic fatty liver disease with metabolic syndrome: a propensity score-matched cohort study. Clin Mol Hepatol. 2015, 21:379-386. 10.3350\/cmh.2015.21.4.379","journal-title":"Clin Mol Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(92)81290-3","article-title":"Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver","volume":"24","author":"Parola M","year":"1992","unstructured":"Parola M, Muraca R, Dianzani I, et al.. Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver. FEBS Lett. 1992, 24:267-270. 10.1016\/0014-5793(92)81290-3","journal-title":"FEBS Lett"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/2047-783x-16-2-76","article-title":"Plasma levels of vitamin E and carotenoids are decreased in patients with Nonalcoholic Steatohepatitis (NASH)","volume":"16","author":"Erhardt A","year":"2011","unstructured":"Erhardt A, Stahl W, Sies H, Lirussi F, Donner A, H\u00e4ussinger D. Plasma levels of vitamin E and carotenoids are decreased in patients with Nonalcoholic Steatohepatitis (NASH). Eur J Med Res. 2011, 16:76-78. 10.1186\/2047-783x-16-2-76","journal-title":"Eur J Med Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12352","article-title":"Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis","volume":"38","author":"Hoofnagle JH","year":"2013","unstructured":"Hoofnagle JH, Van Natta ML, Kleiner DE, et al.. Vitamin E and changes in serum alanine aminotransferase levels in patients with non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2013, 38:134-143. 10.1111\/apt.12352","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/129083-effect-of-vitamin-e-on-clinical-outcomes-in-patients-with-non-alcoholic-fatty-liver-disease-a-meta-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:44Z","timestamp":1707508004000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/129083-effect-of-vitamin-e-on-clinical-outcomes-in-patients-with-non-alcoholic-fatty-liver-disease-a-meta-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.32764","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,21]]}}}